Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Florence's Uffizi Gallery moves treasures to safety after cyberattack - 2Jubilant FoodWorks to scrap Dunkin’ franchise arrangement in India
- 3They died 'doing what they loved': The stories of workers in their 80s who died on the job
- 4Best Disney Palace: Which One Catches Your Creative mind?
- 5Fire Allegedly Triggered by Wedding Cake Sparkler Causes Venue to Go Up in Flames, Leaving Groom with Second-Degree Burns
- The most effective method to Promoter for Cutthroat Medical attendant Compensations in Your Medical services Office
- Are your hormones imbalanced? Doctors explain how to know if you need testing
- IVE 2026 'Show What I Am' Tour: How to get tickets, prices, dates and more
- Landon Donovan knew he couldn’t hide his hair loss. So he turned to fans for help.
- What to know as New York City nurses strike for a 3rd day
- Two policemen injured at religious youth protest in Jerusalem marking Ahuvia Sandak's death
- 6 Fun Urban areas For Seniors To Travel
- Instructions to Pick the Right Senior Protection Plan.
- Figure out How to Adjust Work, Life, and an Internet based Degree
